share_log

Does Cerus (NASDAQ:CERS) Have A Healthy Balance Sheet?

シーラス(ナスダック:CERS)は健全な財務諸表を持っていますか?

Simply Wall St ·  11/12 05:04

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' When we think about how risky a company is, we always like to look at its use of debt, since debt overload can lead to ruin. We note that Cerus Corporation (NASDAQ:CERS) does have debt on its balance sheet. But is this debt a concern to shareholders?

Why Does Debt Bring Risk?

Debt and other liabilities become risky for a business when it cannot easily fulfill those obligations, either with free cash flow or by raising capital at an attractive price. Ultimately, if the company can't fulfill its legal obligations to repay debt, shareholders could walk away with nothing. While that is not too common, we often do see indebted companies permanently diluting shareholders because lenders force them to raise capital at a distressed price. By replacing dilution, though, debt can be an extremely good tool for businesses that need capital to invest in growth at high rates of return. The first step when considering a company's debt levels is to consider its cash and debt together.

How Much Debt Does Cerus Carry?

You can click the graphic below for the historical numbers, but it shows that as of September 2024 Cerus had US$83.4m of debt, an increase on US$78.6m, over one year. However, it also had US$75.6m in cash, and so its net debt is US$7.80m.

big
NasdaqGM:CERS Debt to Equity History November 12th 2024

How Healthy Is Cerus' Balance Sheet?

According to the last reported balance sheet, Cerus had liabilities of US$54.3m due within 12 months, and liabilities of US$80.9m due beyond 12 months. Offsetting these obligations, it had cash of US$75.6m as well as receivables valued at US$24.4m due within 12 months. So its liabilities total US$35.3m more than the combination of its cash and short-term receivables.

Of course, Cerus has a market capitalization of US$330.6m, so these liabilities are probably manageable. However, we do think it is worth keeping an eye on its balance sheet strength, as it may change over time. The balance sheet is clearly the area to focus on when you are analysing debt. But it is future earnings, more than anything, that will determine Cerus's ability to maintain a healthy balance sheet going forward. So if you want to see what the professionals think, you might find this free report on analyst profit forecasts to be interesting.

In the last year Cerus wasn't profitable at an EBIT level, but managed to grow its revenue by 15%, to US$176m. We usually like to see faster growth from unprofitable companies, but each to their own.

Caveat Emptor

Importantly, Cerus had an earnings before interest and tax (EBIT) loss over the last year. Indeed, it lost US$12m at the EBIT level. When we look at that and recall the liabilities on its balance sheet, relative to cash, it seems unwise to us for the company to have any debt. Quite frankly we think the balance sheet is far from match-fit, although it could be improved with time. Another cause for caution is that is bled US$11m in negative free cash flow over the last twelve months. So to be blunt we think it is risky. When analysing debt levels, the balance sheet is the obvious place to start. But ultimately, every company can contain risks that exist outside of the balance sheet. For example, we've discovered 3 warning signs for Cerus that you should be aware of before investing here.

If you're interested in investing in businesses that can grow profits without the burden of debt, then check out this free list of growing businesses that have net cash on the balance sheet.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする